DEFINITIVE PROXY STATEMENT

Company

TENAX THERAPEUTICS, INC.

Filed

August 17, 2015

Period of Report

September 15, 2015

Accession Number

0001354488-15-003929

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →